Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage
Titel:
Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage
Auteur:
Bosma, Karin J. Andrei, Spencer R. Katz, Liora S. Smith, Ashley A. Dunn, Jennifer C. Ricciardi, Valerie F. Ramirez, Marisol A. Baumel-Alterzon, Sharon Pace, William A. Carroll, Darian T. Overway, Emily M. Wolf, Elysa M. Kimple, Michelle E. Sheng, Quanhu Scott, Donald K. Breyer, Richard M. Gannon, Maureen